Molecular Imaging of Metastatic Potential
Open Access
- 3 June 2008
- journal article
- review article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 49 (Suppl 2) , 96S-112S
- https://doi.org/10.2967/jnumed.107.045948
Abstract
If molecular imaging is to prove clinically useful it will have to surpass current, primarily anatomic techniques in terms of sensitivity and the ability to detect minimal changes in tissue. One of the most important tests for molecular imaging is to determine whether it can image the metastatic potential of tumors. Like all predictive endeavors, the imaging of such “potential” is a daunting task, but one that only molecular imaging—rather than standard, anatomic techniques—is likely to solve. Although difficult, imaging of metastatic potential is also arguably the most important task for molecular imaging of cancer because it is generally the dissemination of malignant tissue, not its prolonged residence in an inopportune site, which kills the patient. Below are examples of uses of molecular imaging of metastases as well as of metastatic potential, the former being a far more developed area of clinical inquiry.Keywords
This publication has 180 references indexed in Scilit:
- Modulating metastasis by a lymphangiogenic switch in prostate cancerInternational Journal of Cancer, 2007
- Impact of supervised gene signatures of early hypoxia on patient survivalRadiotherapy and Oncology, 2007
- Metastasis: recent discoveries and novel treatment strategiesPublished by Elsevier ,2007
- Imaging oxygenation of human tumoursEuropean Radiology, 2006
- The multiple uses of fluorescent proteins to visualize cancer in vivoNature Reviews Cancer, 2005
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteinNature Biotechnology, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The Hallmarks of CancerCell, 2000